The control of development and generalization of medical technology is fragmented. Identify control points, and suggest ways to improve them. Distinguish the private and public sectors. Medical technology continues to advance to the highest of levels in recent years; this has brought more and more attention to regulation at the federal, state, and professional level. Medical technology and the control of such technology has also become a controversial issue in healthcare today. The can almost be directly related to the rapidly rising national health care expenses and their relation to the technology. These costs are increasing, whereas, the benefits or effectiveness of the technology still have to prove themselves. The FDA is one control point for medical technologies in the public sector. The FDA reviews and maintains the approval of medical devices and drugs, which is an absolute requirement before the drugs and devices can even be placed on the market. In addition to devices, the FDA also regulates new drugs (Longest & Darr, 2008). For example, our Medicare program has developed a process for making reimbursement decisions based on their assessments of the technology. Current debate has raised proposals to shift to the prospective payment based on current technological changes. Though, the private nature of the health care system and the limited leverage of the Medicare program limit the power of our government to make any immediate change.
The electronic health record promises to revolutionize the delivery of health services. Identify the advantages and disadvantages for the patient and for providers.
Electronic health records (EHR) provide the opportunity for healthcare organizations to improve quality of care and patient safety. They also represent a huge potential for cost savings and can also decrease organizational inefficiencies (Longest, B. J., & Darr, K. 2008).Electronic records have several advantages over paper records, the first being...
Please join StudyMode to read the full document